Resistance to adefovir dipivoxil therapy associated with the selection of a novel mutation in the HBV polymerase. - Wikidata - wikimedia - TriplyDB

Resistance to adefovir dipivoxil therapy associated with the selection of a novel mutation in the HBV polymerase.

Resistance to adefovir dipivoxil therapy associated with the selection of a novel mutation in the HBV polymerase.

http://www.wikidata.org/entity/Q44532948

about

Adefovir dipivoxil for adults with lamivudine-resistant chronic hepatitis B virus infection Adefovir dipivoxil versus other antiviral drugs for chronic hepatitis B Adefovir dipivoxil for chronic hepatitis B Adefovir dipivoxil for chronic hepatitis B Management of HBV Infection in Liver Transplantation Patients Basal core promoter and precore mutations in the hepatitis B virus genome enhance replication efficacy of Lamivudine-resistant mutants Searching for chronic hepatitis B patients in a low prevalence area--role of racial origin Advances in Molecular Diagnosis of HBV Infection and Drug Resistance Advances in immunomodulating therapy of HBV infection Successful rescue therapy with tenofovir in a patient with hepatic decompensation and adefovir resistant HBV mutant KASL clinical practice guidelines: management of chronic hepatitis B Genetic variation of hepatitis B virus and its significance for pathogenesis The Molecular and Structural Basis of HBV-resistance to Nucleos(t)ide Analogs Direct acting antivirals for the treatment of chronic viral hepatitis Antiviral drug resistance: mechanisms and clinical implications Pre-existing mutations in reverse transcriptase of hepatitis B virus in treatment-naive Chinese patients with chronic hepatitis B Safety and efficacy of telbivudine for the treatment of chronic hepatitis B Virologic and clinical outcomes of hepatitis B virus infection in HIV-HBV coinfected transplant recipients Outcomes of patients with hepatitis B who developed antiviral resistance while on the liver transplant waiting list Clinical emergence of entecavir-resistant hepatitis B virus requires additional substitutions in virus already resistant to Lamivudine.Resistance to adefovir dipivoxil in lamivudine resistant chronic hepatitis B patients treated with adefovir dipivoxil Management of chronic hepatitis B virus infection: current perspectives for the nurse practitioner.Binding sensitivity of adefovir to the polymerase from different genotypes of HBV: molecular modeling, docking and dynamics simulation studies.Hepatitis B viral surface mutations in patients with adefovir resistant chronic hepatitis B with A181T/V polymerase mutations.Selection and counterselection of the rtI233V adefovir resistance mutation during antiviral therapy.Current antiviral therapy for chronic hepatitis B.Antiviral therapy and resistance with hepatitis B virus infection.Application of hepatitis B virus replication mouse model Inhibition of hepatitis B virus production by Boehmeria nivea root extract in HepG2 2.2.15 cells.Antiviral effect of oral administration of tenofovir disoproxil fumarate in woodchucks with chronic woodchuck hepatitis virus infection.Virologic response at 12 months of treatment predicts sustained antiviral efficacy in patients with adefovir-treated Lamivudine-resistant chronic hepatitis B Alpha/beta interferon differentially modulates the clearance of cytoplasmic encapsidated replication intermediates and nuclear covalently closed circular hepatitis B virus (HBV) DNA from the livers of hepatocyte nuclear factor 1alpha-null HBV transg Unsuccessful therapy with adefovir and entecavir-tenofovir in a patient with chronic hepatitis B infection with previous resistance to lamivudine: a fourteen-year evolution of hepatitis B virus mutations Emergence of the rtA181T/sW172* mutant increased the risk of hepatoma occurrence in patients with lamivudine-resistant chronic hepatitis B.Evaluation of intra-host variants of the entire hepatitis B virus genome Importance of serum concentration of adefovir for Lamivudine-adefovir combination therapy in patients with lamivudine-resistant chronic hepatitis B.Viral hepatitis in HIV infection.Complex dynamics of hepatitis B virus resistance to adefovir.Hepatitis B virus gene mutations in liver diseases: a report from New Delhi.Th1 and Th2 immune response in chronic hepatitis B patients during a long-term treatment with adefovir dipivoxil.

P2860

Q24187530-F3ABA708-96F5-4A8B-9008-5946E9326A31 Q24234842-58271DF5-A162-4898-A8DF-F89E5EF51E4E Q24234931-6685F0EB-C25E-4C3C-BDF9-09189D5E4086 Q24235209-7D7DE8ED-5DB0-4879-9CED-7781D6D037D3 Q24529103-E5797F94-8DAD-4F84-BDF1-C58966163A07 Q24563991-93C574E0-CFC0-4ABD-9122-D497CE8AF31D Q24804377-F84E1E52-88A4-43D7-9608-7F01F44D0CB8 Q24810144-6BADC985-51B0-4148-9B37-A4797B22BF9D Q24810147-6ACA6316-1C11-4CF0-A98A-EC3B2E0DC832 Q25256648-F48F9541-8462-459C-A625-46ACF42506E5 Q26752475-49C86651-24CB-4711-9895-453A0667B1AB Q26772348-5164D531-CB98-44E5-97C8-5A3B67133AE0 Q26781795-91318D37-F601-4300-9B1C-F916851940DC Q27022216-26ABC5DB-987F-4230-80EB-2CD767D25F3E Q28282376-C930F785-BAFE-4090-92C1-5B335B2266A5 Q28545179-9650D459-49BB-465D-B1E1-2AE067B716F5 Q28972486-CE807120-EA51-48DF-844D-9E7B7309B8DA Q30431051-9021931D-1083-4472-A211-748DA35ED2B8 Q30440211-D280A9F2-C545-4947-9575-280D3A01AC27 Q33206221-480179F1-BCE4-4DDE-B3DF-F57805B1145B Q33233245-9196B42F-30FC-45F8-9F33-8748CEF33771 Q33242705-7AA98F29-E845-4C0D-B529-C288AD74BEF4 Q33572382-C64CF575-9782-42B3-9702-2009F4ED9C0C Q33610009-A927B9B9-72BE-4CCC-9A85-5326EB700B24 Q33627462-67D485C4-60FE-40D8-B2AF-45676BDAE643 Q33631693-AFEED0E2-DC5B-4B0D-AE07-5B8851F5B6D2 Q33787531-AD0A150C-1DDB-4865-982A-0E3315AA6E26 Q33812160-CAB70BD8-16E4-4D3C-A379-08648D38B3FD Q33869291-8DF1BF63-C09C-4ED8-A963-AC986A8294BA Q33883722-0086152C-FC6C-4F21-BBD0-A7F3C896E37E Q33918275-F03F2C1E-DD45-4A0D-8069-5932AB3438EF Q33930340-0B4FAB16-2841-45E1-A17C-BAB4FE430D3D Q33940140-576209B4-B860-406E-9DFD-9BEAFB03E4D5 Q34024728-A923801D-D79C-4B1E-B3BF-0AEA4F48A154 Q34032030-221906DB-A9A5-45B8-AC69-7AD7F6DAD4F7 Q34045308-88A29D78-8E52-42F3-8452-C726C6D566E8 Q34086980-8937DC59-CE3F-4539-A69E-CCE08ED8555F Q34208672-27C0E414-8E30-493C-B5FE-13F4B78EDEF3 Q34312096-B78A26F6-26AD-4478-8FCA-0CF80F5AAAC2 Q34362568-56C84ECE-3AAB-4EE7-8099-13FFF91A28B6

P2860

Resistance to adefovir dipivoxil therapy associated with the selection of a novel mutation in the HBV polymerase.

http://www.wikidata.org/entity/Q44532948

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年学术文章

@wuu

2003年学术文章

@zh

2003年学术文章

@zh-cn

2003年学术文章

@zh-hans

2003年学术文章

@zh-my

2003年学术文章

@zh-sg

2003年學術文章

@yue

2003年學術文章

@zh-hant

name

Resistance to adefovir dipivox ...... utation in the HBV polymerase.

@en

Resistance to adefovir dipivox ...... utation in the HBV polymerase.

@nl

type

label

Resistance to adefovir dipivox ...... utation in the HBV polymerase.

@en

Resistance to adefovir dipivox ...... utation in the HBV polymerase.

@nl

prefLabel

Resistance to adefovir dipivox ...... utation in the HBV polymerase.

@en

Resistance to adefovir dipivox ...... utation in the HBV polymerase.

@nl

P1433

Q44532948-7E0F3BDC-564E-4477-B601-D7C8A77EE1B2

P1476

Q44532948-30D07E2D-5F4D-4660-82A6-4D40A9FEEC5C

P2093

Q44532948-031512D6-F298-4147-A239-16B4956203A3

Q44532948-03FF2915-937F-4D30-A9E4-E62BD26F555E

Q44532948-0A59A4C9-F521-4A04-9BB0-053D1112DBE3

Q44532948-16C4B51B-BC39-4FCC-A62B-D2DB22393BCD

Q44532948-2EA03A15-BB5E-4361-94EA-F0EACCB38F34

Q44532948-3916888F-58DE-4A87-A714-382C45DFEB05

Q44532948-4D68172F-22B7-4D2E-87CC-8614ABD16156

Q44532948-510958B0-4968-480C-9B5A-AE805CF77E53

Q44532948-6C480B3E-93E9-47F5-8FCE-9220DA3A213A

Q44532948-97215342-6B7C-499D-90E2-9A65933980CB

P304

Q44532948-99EB40AC-D94B-45EA-814A-1B07C4EE8F1F

P31

Q44532948-CEFC6ED2-8D1C-42EE-8796-BF9A91401C6A

P356

Q44532948-60716846-78AF-44F6-96B3-A8AFC6EC50E5

P407

Q44532948-4523FEFE-CF31-442F-B94B-18C7701378E2

P433

Q44532948-02301440-B5C7-44FF-ADD7-EF0B42067203

P478

Q44532948-5F6E9A0A-ED39-430E-80C9-78617A5610B5

P577

Q44532948-D259EDC6-FA41-44B6-9A5A-1B29B99E88DF

P698

Q44532948-39B76DC9-C991-4FC2-A6F7-19BF77133CFC

P356

S0016-5085(03)00939-9

P1433

Gastroenterology

P1476

Resistance to adefovir dipivox ...... utation in the HBV polymerase.

@en

P2093

Angeline Bartholomeusz

http://www.w3.org/2001/XMLSchema#string

Anna Ayres

http://www.w3.org/2001/XMLSchema#string

Carol Brosgart

http://www.w3.org/2001/XMLSchema#string

Craig Gibbs

http://www.w3.org/2001/XMLSchema#string

Danielle Colledge

http://www.w3.org/2001/XMLSchema#string

Huiling Yang

http://www.w3.org/2001/XMLSchema#string

Peter Angus

http://www.w3.org/2001/XMLSchema#string

Rhys Vaughan

http://www.w3.org/2001/XMLSchema#string

Rosalind Edwards

http://www.w3.org/2001/XMLSchema#string

Shelly Xiong

http://www.w3.org/2001/XMLSchema#string

P304

292-297

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/S0016-5085(03)00939-9

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

125

http://www.w3.org/2001/XMLSchema#string

P577

2003-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12891527

http://www.w3.org/2001/XMLSchema#string